It walls off Big Pharma’s natural competitors, especially if the drugs function as antidepressants, anti-anxiety medications, or alternative non-addictive painkillers. Title VII of the applicable federal code restricts the ONDCP from funding research or supporting the legalization of Schedule I drugs in any form. The alternative FDA approval pathway mentioned in Title VII that allows a naturally occurring drug to be distributed is expensive to navigate. Federal and state governments are allowed under Title VII to deprive American citizens of safe, effective, low-cost medications. They can demand enforcement of the anti-trust laws with respect to pharmaceutical corporations and natural drugs.